Abstract: Method and Apparatus for harvesting crops, the apparatus (1) comprising a carriage (2) provided with a harvesting device (41), a ground height measuring device to measure or estimate the ground height (S2) at each harvested crop, a crop height measuring device to measure the height of a crop(S4), a processor operatively connected to the ground height measuring device to generate baseline ground data (S3) and operatively connected to the crop height measuring device to determine a desired harvest height (S5), a comparator to compare the baseline ground data to the desired harvest height to determine if a particular crop is to be harvested by the harvesting device.

Abstract: An apparatus (1) for harvesting crops, the apparatus (1) comprises a carriage (2), sensing means (3), a ground motion sensor (6) and a harvesting device (4), where the sensing means (3) is configured or configurable to determine the location of a first crop, the ground motion sensor (6) is operated or operable to determine the motion of the carriage (2) relative to the ground, the location data and the motion data being utilized to cause the harvesting device (4) to move to and harvest the first crop.

Abstract: Method and Apparatus for harvesting crops, the apparatus (1) comprising a carriage (2) provided with a harvesting device (41), a ground height measuring device to measure or estimate the ground height (S2) at each harvested crop, a crop height measuring device to measure the height of a crop(S4), a processor operatively connected to the ground height measuring device to generate baseline ground data (S3) and operatively connected to the crop height measuring device to determine a desired harvest height (S5), a comparator to compare the baseline ground data to the desired harvest height to determine if a particular crop is to be harvested by the harvesting device.

Abstract: The current invention relates to a method of developing a personalized medicine business plan for a targeted therapy. For example, one method includes obtaining a plurality of variables; creating an archive of scenarios; determining a theranostic; collating at least some of the plurality of financial variables; creating an archive of scenarios; generating predicted revenues; comparing each of the scenarios in the archive with the hypothetical business scenario; and generating an intended personalized medicine business plan.

Abstract: Various solutions for processing timeline enhancement with respect to user equipment and network apparatus in mobile communications are described. An apparatus may determine whether a latency requirement of a service is less than a threshold value. The apparatus may use a first processing time capability to perform a transmission in an event that the latency requirement of the service is not less than the threshold value. The apparatus may use a second processing time capability to perform the transmission in an event that the latency requirement of the service is less than the threshold value. The apparatus may apply a scheduling restriction/optimization to perform the transmission when using the second processing time capability.

Abstract: An apparatus (1) for harvesting crops, the apparatus (1) comprises a carriage (2), sensing means (3), a ground motion sensor (6) and a harvesting device (4), where the sensing means (3) is configured or configurable to determine the location of a first crop, the ground motion sensor (6) is operated or operable to determine the motion of the carriage (2) relative to the ground, the location data and the motion data being utilized to cause the harvesting device (4) to move to and harvest the first crop.

Abstract: A method of identifying whether a first product should be sold or marketed, associated with a predetermined diagnostic, based on the impact of the predetermined diagnostic on one or more other products which are similar to the first product in one or more respect, and where not all the other products have experienced the predetermined diagnostic.

Abstract: A method of comparing a first brand with one or more second brands by identifying a differentiation factor between the first and second brands, the method comprising the following steps. The first step entails identifying a plurality of elements which can differentiate between one brand and another. Secondly, a consensus score is determined with respect to the first brand and the or each second brand based on the plurality of elements. Next, the consensus score of the first brand is compared with the or each second brand in order to identify elements for which the first brand has a substantially equal or higher score than the or each second brand. Finally, the identified elements for which the first brand has a substantially equal or higher score than the or each second brand are displayed in a visual manner to enable identification of key marketing criteria which can position the first brand relative to the or each second brand.

Abstract: A method of determining a theranostic plan for a pharmaceutical, the plan being optimized in terms of return on investment (ROI), the method comprising, determining a plurality of planning frameworks which take the pharmaceutical from a point of conception to a point of marketing and beyond, for the or each framework determining a plurality of planning steps which lead to the definition of a plurality of required decisions, effecting a plurality of decisions corresponding to the required decisions, carrying out the plurality of decisions in a predetermined order, based on the framework and planning steps, so as to put the theranostic plan into effect, wherein the carrying out the decisions is made so as to optimize the ROI of the theranostic plan.

Abstract: A method of developing a personalised medicine business plan comprising the steps of: obtaining a plurality of variables associated with an intended personalised medicine business plan; generating a predicted revenue from the plurality of variables associated with the intended personalised medicine business plan; collating the plurality of variables associated with the intended personalised medicine business plan and the predicted revenue to generate a hypothetical business scenario; creating an archive of scenarios comprising data relating to personalised medicine, said data being acquired from real-world case studies; comparing each of the scenarios in the archive with the hypothetical business scenario to identify a first archived scenario that most closely matches at least some of the variables of the hypothetical business scenario; and extracting information from the first archived scenario, said information being used to justify the intended personalised medicine business plan and provide one or more

Abstract: The invention relates to hosts containing constructs with genes from the starch pathway. More typically the present invention relates to bacterial hosts that form plant like starches. Additionally the present invention relates to plant hosts that have genes from the starch pathway. The invention further relates to the starches produced by said hosts.

Abstract: The present invention relates to a recombinant nucleic acid encoding a hybrid polypeptide which comprises a transit peptide for the translocation of the polypeptide into an appropriate organelles such as plastids, a starch-encapsulating region from maize starch synthase and a payload polypeptide, wherein said payload polypeptide can be either N- or C-terminal to the starch encapsulating region. The invention also relates to the expression vectors comprising said nucleic acid, and hosts comprising the said vector. Also, the invention encompasses methods of producing the hybrid polypeptide thereof from starch and particularly from starch granules, and industrial uses of the payload polypeptide recombinantly produced in said hybrid polypeptide wherein said payload polypeptide is a biologically active molecule.

Abstract: This invention relates to a method of producing a starch with unique functionality in plants through mutagenesis, and/or using biotechnology, and/or breeding practices. Further the invention relates to the starch from maize plants and/or other plants which produce starch storing organs which contain low amylose starch which has an amylose content between 1.5% and 15% and preferably between 1.5% and 10% and most preferably 1.5 and 8%. The invention includes starch extracted from such novel grain due to at least one mutation induced by ethyl methanesulfonate. Additionally, the invention uses a biotechnology approach involving controlling the activity of the granule bound starch synthase enzyme in starch storing organ. The invention includes the use of the starch for its cooking, paste, and gel properties.

Abstract: The invention relates to hosts containing constructs with genes from the starch pathway. More typically the present invention relates to bacterial hosts that form plant like starches. Additionally the present invention relates to plant hosts that have genes from the starch pathway. The invention further relates to the starches produced by said hosts.

Abstract: The present invention provides grain, seed, feed made from the grain or seed, pet food made from the grain, and food products made from the grain. The grain may be maize grain with the following characteristics: oil burdened, elevated protein content, and low phytate levels. The combination of oil burdened, protein laden, and decreased phytate characteristics in grain makes a grain that provides more calories, protein and phosphorus and other nutrients to the feeding animal. Pet foods, and animal feeds and corn food products made of the present invention will provide increased nutrition because of the increased bioavailability of the components of the grain.

Abstract: The invention provides transgenic corn seed, which expresses a gene encoding a double mutant of the E. coli glgC gene in endosperm plastids, wherein the mutant protein has a proline to aspartic acid substitution at amino acid 295 and a glutamic acid to lysine substitution at amino acid 296. The transgenic corn seed of the invention is characterized by enhanced levels of a number of amino acids and oil, when compared to isogenic corn seed, which does not express the transgene in an endosperm plastid. However, the amount of starch in the transgenic corn seed of the invention is decreased or unchanged when compared to the amount of starch in the isogenic control corn seed.

Abstract: The present invention provides grain, seed, feed made from the grain or seed, pet food made from the grain, and food products made from the grain. The grain may be maize grain with the following characteristics: oil burdened, elevated protein content, and low phytate levels. The combination of oil burdened, protein laden, decreased phytate characteristics in grain makes a grain that provides more calories, protein and phosphorus and other nutrients to the feeding animal. Pet foods, and animal feeds and corn food products made of the present invention will provide increased nutrition because of the increased bioavailability of the components of the grain.

Abstract: The invention relates to a transgenic or mutated plant having genomic material which alters the normal starch synthesis pathway within the plant. More specifically, the present invention relates to a plant having a genotype which creates new forms of starch in significant quantity. Particularly, the invention relates to grain having an embryo with a genotype heterozygous for two or more wild type genes (for example, Aa/Bb) and an endosperm having a genotype heterozygous for such genes (for example, AAa/BBb or AAa/bbB or aaA/BBb or aaA/bbB) and the starch produced therefrom.

Abstract: Hybrid polypeptides are provided formed with encapsulating regions from genes that encode for anabolic proteins. More particularly, the present invention relates to recombinant nucleic acid molecules that code for genes which encapsulate an attached protein within a matrix; preferably, these genes encapsulate a desired (“payload”) polypeptide within starch, and more specifically within the starch granule matrix. Expression vectors comprising these recombinant nucleic acid molecules, and hosts therefor, and more specifically the starch-bearing portions of such hosts, transformed with such vectors, are also provided. Preferably, grain containing a foreign protein encapsulated within the starch is provided, useful to produce mammalian, fish and avian food. The invention also encompasses methods of producing purified protein from starch and particularly from starch granules, and industrial uses of such protein.

Abstract: Hybrid polypeptides are provided formed with encapsulating regions from genes that encode for anabolic proteins. More particularly, the present invention relates to recombinant nucleic acid molecules that code for genes which encapsulate an attached protein within a matrix; preferably, these genes encapsulate a desired ("payload") polypeptide within starch, and more specifically within the starch granule matrix. Expression vectors comprising these recombinant nucleic acid molecules, and hosts therefor, and more specifically the starch-bearing portions of such hosts, transformed with such vectors, are also provided. Preferably, grain containing a foreign protein encapsulated within the starch is provided, useful to produce mammalian, fish and avian food. The invention also encompasses methods of producing purified protein from starch and particularly from starch granules, and industrial uses of such protein.